The natural history of macroprolactinaemia

European Journal of Endocrinology

Volumn 166, Issue 4, 2012, Pages 625-629

  Hattori, Naoki ^a   Adachi, Takashi ^b   Ishihara, Takashi ^c   Shimatsu, Akira ^d  

^a RITSUMEIKAN UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE ANTIBODY; IMMUNOGLOBULIN G; IODINE 125; MACROGOL; MACROPROLACTIN; PROLACTIN; PROLACTIN AUTOANTIBODY; PROTEIN G; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GEL FILTRATION CHROMATOGRAPHY; HORMONE BINDING; HORMONE DETERMINATION; HOSPITAL PERSONNEL; HUMAN; HYPERPROLACTINEMIA; MACROPROLACTINEMIA; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL;

ADULT; AUTOANTIBODIES; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; PROLACTIN; RADIOIMMUNOASSAY; TIME FACTORS;

EID: 84859378546     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-1007     Document Type: Article

References (22)

1. Suh HK & Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. Journal of Clinical Endocrinology and Metabolism 1974 39 928-935. (doi:10.1210/jcem-39-5-928)
2. Soong YK, Ferguson KM, McGarrick G & Jeffcoate SL. Size heterogeneity of immunoreactive prolactin in hyperprolactinaemic serum. Clinical Endocrinology 1982 16 259-265. (doi:10.1111/j.1365-2265.1982.tb00715.x)
3. Hattori N, Ishihara T, Ikekubo K, Moridera K, Hino M & Kurahachi H. Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism 1992 75 1226-1229. (doi:10.1210/jc.75.5.1226)
4. Bjøro T, Mørkrid L, Wergeland R, Turter A, Kvistborg A, Sand T & Torjesen P. Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scandinavian Journal of Clinical and Laboratory Investigation 1995 55 139-147. (doi:10.3109/00365519509089606)
5. Leslie H, Courtney CH, Bell PM, Hadden DR, McCance DR, Ellis PK, Sheridan B & Atkinson AB. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. Journal of Clinical Endocrinology and Metabolism 2001 86 2743-2746. (doi:10.1210/jc.86.6.2743)
6. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A, Martin PM, Jaquet P & Brue T. Macroprolactinemia revisited: a study on 106 patients. Journal of Clinical Endocrinology and Metabolism 2002 87 581-588. (doi:10.1210/jc.87.2.581)
7. Gibney J, Smith TP & McKenna TJ. The impact on clinical practice of routine screening for macroprolactin. Journal of Clinical Endocrinology and Metabolism 2005 90 3927-3932. (doi:10.1210/jc.2004-2234)
8. Gibney J, Smith TP & McKenna TJ. Clinical relevance of macroprolactin. Clinical Endocrinology 2005 62 633-643. (doi:10.1111/j.1365- 2265.2005.02243.x)
9. McKenna TJ. Should macroprolactin be measured in all hyperprolactinaemic sera? Clinical Endocrinology 2009 71 466-469. (doi:10.1111/j.1365-2265.2009. 03577.x)
10. Hattori N, Ishihara T & Saiki Y. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clinical Endocrinology 2009 71 702-708. (doi:10.1111/j.1365-2265.2009.03570.x)
11. De Schepper J, Schiettecatte J, Velkeniers B, Blumenfeld Z, Shteinberg M, Devroey P, Anckaert E, Smitz J, Verdood P, Hooghe R & Hooghe-Peters E. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. European Journal of Endocrinology 2003 149 201-207. (doi:10.1530/eje.0.1490201)
12. Sapin R & Kertesz G. Macroprolactin detection by precipitation with protein A-sepharose: a rapid screening method compared with polyethylene glycol precipitation. Clinical Chemistry 2003 49 502-505. (doi:10.1373/49.3.502)
13. Amadori P, Dilberis C, Marcolla A, Pinamonti M, Menapace P & Valentini A. Identification of IgG-immunocomplex macroprolactin with an immunometric "sandwich" system: technical and clinical considerations. Journal of Endocrinological Investigation 2004 27 1022-1028.
14. Kavanagh-Wright L, Smith TP, Gibney J & McKenna TJ. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Clinical Endocrinology 2009 70 599-605. (doi:10.1111/j.1365-2265.2008.03402.x)
15. Hattori N, Ishihara T, Saiki Y & Shimatsu A. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up. Clinical Endocrinology 2010 73 792-797. (doi:10.1111/j.1365-2265.2010.03880.x)
16. Hattori N & Inagaki C. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. Journal of Clinical Endocrinology and Metabolism 1997 82 3107-3110. (doi:10.1210/jc.82.9.3107)
17. Altman DG. Some common problems in medical research. In Practical Statistics for Medical Research, 1st edn, ch 14, pp 396-439. London: Chapman & Hall, 1991.
18. Ichihara K. Smirnov test for extreme value. In Statistics for Bioscience, pp 284-287. Tokyo: Nankodo, 1989.
19. Fabre-Brue C, Roth E, Simonin G, Palix C, Martin PM & Brue T. Macroprolactinemia: a cause of hyperprolactinemia in childhood. Journal of Pediatric Endocrinology & Metabolism 1997 10 411-417. (doi:10.1515/JPEM. 1997.10.4.411)
20. Fideleff HL, Ruibal G, Boquete H, Pujol A, Sequera A & Sobrado P. Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia. Hormone Research 2000 53 16-19. (doi:10.1159/000023507)
21. Kubo T, Furujo M, Mori S, Imai K, Ueda Y, Tsukahara K, Morita H, Ogura K, Fukuhara S, Shimizu J, Koyama T, Kanadani T, Shiraga H, Shinozuka M, Terasaki T & Hattori N. An infant case of macroprolactinemia with transient idiopathic central precocious puberty. Endocrine Journal 2007 54 825-828. (doi:10.1507/endocrj.K07-010)
22. Wallace IR, Satti N, Courtney CH, Leslie H, Bell PM, Hunter SJ, McCance DR, Sheridan B & Atkinson AB. Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. Journal of Clinical Endocrinology and Metabolism 2010 95 3268-3271. (doi:10.1210/jc.2010- 0114)